Shots:
The EMA’s CHMP has granted positive opinions and approvals to 5 Biologics and 2 New Chemical Entities in February 2025, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Merck’s Welireg to treat Von Hippel-Lindau & Renal Cell Carcinoma
PharmaShots has compiled a list of 6 drugs…
Shots:
The EMA’s CHMP has granted positive opinions to 5 Biologics in January 2025, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Merck’s Capvaxive to treat Pneumococcal Disease
PharmaShots has compiled a list of 4 drugs that have been granted positive opinions and approvals by the EMA’s…
Shots:
The EMA’s CHMP has granted positive opinions to 5 Biologics and 4 New Chemical Entities in December 2024, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Galderma’s Nemluvio to treat Prurigo Nodularis and Atopic Dermatitis
PharmaShots has compiled a list of 9 drugs that have been granted positive…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of December 2024
The US FDA has approved a total of 10 new drugs including 4 new molecular entities and 6 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was BMS’ Opdivo Qvantig…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of November 2024
The US FDA has approved a total of 5 new drugs including 4 new molecular entities and 1 biologic leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was Jazz Pharmaceuticals’ Ziihera…
Shots:
The EMA’s CHMP has granted positive opinions to 5 Biologics and 1 New Chemical Entity in October 2024, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Novo Nordisk’s Alhemo to treat Haemophilia A or B with inhibitors and AstraZeneca & Ionis’ Wainzua for Hereditary Transthyretin-Mediated Amyloidosis
PharmaShots has…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of October 2024
The US FDA has approved a total of 4 new drugs including 2 new molecular entities and 2 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drugs were Pfizer’s Hympavzi for…
Shots:
The EMA’s CHMP has granted positive opinion to 4 Biologics and 1 New Chemical Entity in September 2024, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were AbbVie’s Elahere to treat Ovarian Cancer and Pfizer’s Hympavzi for Hemophilia A and B
PharmaShots has compiled a list of 3 drugs that have been…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024
The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry
The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…
The healthcare industry is constantly changing, with new technologies, regulations, policies, and best practices emerging daily. Therefore, healthcare professionals need to stay up to date and informed to provide quality care, improve their skills, and advance their careers. Staying current with industry changes — and mastering a constantly changing healthcare landscape — is paramount across…

